|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1999-12-21
|
|
pubmed:abstractText |
To compare positron emission tomography (PET) using 18-fluoro-2-deoxyglucose (FDG) with conventional clinical staging in unselected patients with germ cell cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1527-9995
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
900-4
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10565755-Adult,
pubmed-meshheading:10565755-Aged,
pubmed-meshheading:10565755-Fluorodeoxyglucose F18,
pubmed-meshheading:10565755-Humans,
pubmed-meshheading:10565755-Male,
pubmed-meshheading:10565755-Middle Aged,
pubmed-meshheading:10565755-Neoplasm Staging,
pubmed-meshheading:10565755-Neoplasms, Germ Cell and Embryonal,
pubmed-meshheading:10565755-Predictive Value of Tests,
pubmed-meshheading:10565755-Radiopharmaceuticals,
pubmed-meshheading:10565755-Testicular Neoplasms,
pubmed-meshheading:10565755-Tomography, Emission-Computed
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?--Results of a study in 50 patients.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, Aachen University of Technology, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|
